← Open Payments lookup

BRIAN CARY: Open Payments

NPI 1376733790 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$497 in 18 payments from 9 companies in 2025. Trend: 2023 $241 · 2024 $369 · 2025 $497

Food & beverage: $398Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.7$217
Gilead Sciences, Inc.2$49
Merck Sharp & Dohme LLC2$49
Celgene Corporation2$47
Caris MPI, Inc.1$41
AstraZeneca Pharmaceuticals LP1$31
ARRAY BIOPHARMA INC1$28
Stemline Therapeutics Inc.1$20
Eisai Inc.1$15

Products named: ERLEADA, Trodelvy, KEYTRUDA, REBLOZYL, MI CANCER SEEK, RYBREVANT, LORBRENA, TALVEY.

Industry payments across CA — which companies pay providers there.